Visual Abstract

Visual Abstract
Visual Abstract.
View largeDownload slide
Keywords:
Chronic kidney disease, Awareness, Patient education

Background: The majority of people with chronic kidney disease (CKD) are unaware of their kidney disease. Assessing the clinical significance of increasing CKD awareness has critical public health and healthcare delivery implications. Whether CKD awareness among persons with CKD is associated with longitudinal health behaviors, disease management, and health outcomes is unknown. Methods: We analyzed data from participants with CKD in the REasons for Geographic And Racial Differences in Stroke study, a national, longitudinal, population-based cohort. Our predictor was participant CKD awareness. Outcomes were (1) health behaviors (smoking avoidance, exercise, and nonsteroidal anti-inflammatory drug use); (2) CKD management indicators (angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use, statin use, systolic blood pressure, fasting blood glucose, and body mass index); (3) change in estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR); and (4) health outcomes (incident end-stage kidney disease [ESKD], coronary heart disease [CHD], stroke, and death). Logistic and linear regressions were used to examine the association of baseline CKD awareness with outcomes of interest, adjusted for CKD stage and participant demographic and clinical factors. Results: Of 6,529 participants with baseline CKD, 285 (4.4%) were aware of their CKD. Among the 3,586 participants who survived until follow-up (median 9.5 years), baseline awareness was not associated with subsequent odds of health behaviors, CKD management indicators, or changes in eGFR and UACR in adjusted analyses. Baseline CKD awareness was associated with increased risk of ESKD (adjusted hazard ratio [aHR] 1.44; 95% CI 1.08–1.92) and death (aHR 1.18; 95% CI 1.00–1.39), but not with subsequent CHD or stroke, in adjusted models. Conclusions: Individuals aware of their CKD were more likely to experience ESKD and death, suggesting that CKD awareness reflects disease severity. Most persons with CKD, including those that are high-risk, remain unaware of their CKD. There was no evidence of associations between baseline CKD awareness and longitudinal health behaviors, CKD management indicators, or eGFR decline and albuminuria.

Keywords:
Chronic kidney disease, Awareness, Patient education
1.
Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis. 2010 May;17(3):225–36.
2.
Vassalotti JA, Li S, McCullough PA, Bakris GL. Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease. Semin Nephrol. 2010 Jan;30(1):66–73.
3.
Shirazian S, Diep R, Jacobson AM, Grant CD, Mattana J, Calixte R. Awareness of Chronic Kidney Disease and Depressive Symptoms: National Health and Nutrition Examination Surveys 2005-2010. Am J Nephrol. 2016;44(1):1–10.
4.
Plantinga LC, Boulware LE, Coresh J, Stevens LA, Miller ER 3rd, Saran R, et al. Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med. 2008 Nov;168(20):2268–75.
5.
Tuot DS, Plantinga LC, Judd SE, Muntner P, Hsu CY, Warnock DG, et al.; REGARDS Investigators. Healthy behaviors, risk factor control and awareness of chronic kidney disease. Am J Nephrol. 2013;37(2):135–43.
6.
Whaley-Connell A, Shlipak MG, Inker LA, Kurella Tamura M, Bomback AS, Saab G, et al.; Kidney Early Evaluation Program Investigators. Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med. 2012 Jul;125(7):661–9.
7.
Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, et al. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25(3):135–43.
8.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009 May;150(9):604–12.
9.
Gillett SR, Boyle RH, Zakai NA, McClure LA, Jenny NS, Cushman M. Validating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort. Clin Biochem. 2014 Nov;47(16-17):243–6.
10.
Stroke–1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke. 1989 Oct;20(10):1407–31.
11.
Howard G, Cushman M, Kissela BM, Kleindorfer DO, McClure LA, Safford MM, et al.; REasons for Geographic And Racial Differences in Stroke (REGARDS) Investigators. Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass. Stroke. 2011 Dec;42(12):3369–75.
12.
Safford MM, Brown TM, Muntner PM, Durant RW, Glasser S, Halanych JH, et al.; REGARDS Investigators. Association of race and sex with risk of incident acute coronary heart disease events. JAMA. 2012 Nov;308(17):1768–74.
13.
Halanych JH, Shuaib F, Parmar G, Tanikella R, Howard VJ, Roth DL, et al. Agreement on cause of death between proxies, death certificates, and clinician adjudicators in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am J Epidemiol. 2011 Jun;173(11):1319–26.
14.
Olubowale OT, Safford MM, Brown TM, Durant RW, Howard VJ, Gamboa C, et al. Comparison of Expert Adjudicated Coronary Heart Disease and Cardiovascular Disease Mortality With the National Death Index: Results From the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. J Am Heart Assoc. 2017 May;6(5):6.
15.
Fine JP, Gray RJ. A Proportional Hazards Model for the Subdistribution of a Competing Risk. J Am Stat Assoc. 1999;94(446):496–509.
16.
Tuot DS, Plantinga LC, Hsu CY, Powe NR. Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes? Am J Nephrol. 2012;35(2):191–7.
17.
Schrauben SJ, Cavanaugh KL, Fagerlin A, Ikizler TA, Ricardo AC, Eneanya ND, et al. The Relationship of Disease-Specific Knowledge and Health Literacy With the Uptake of Self-Care Behaviors in CKD. Kidney Int Rep. 2019 Oct;5(1):48–57.
18.
Gheewala PA, Peterson GM, Zaidi ST, Jose MD, Castelino RL. Public knowledge of chronic kidney disease evaluated using a validated questionnaire: a cross-sectional study. BMC Public Health. 2018 Mar;18(1):371.
19.
Molnar AO, Akbari A, Brimble KS. Perceived and Objective Kidney Disease Knowledge in Patients With Advanced CKD Followed in a Multidisciplinary CKD Clinic. Can J Kidney Health Dis. 2020 Feb;7:2054358120903156.
20.
Narva AS, Norton JM, Boulware LE. Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care. Clin J Am Soc Nephrol. 2016 Apr;11(4):694–703.
21.
Tuot DS, Plantinga LC, Hsu CY, Jordan R, Burrows NR, Hedgeman E, et al.; Centers for Disease Control Chronic Kidney Disease Surveillance Team. Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction. Clin J Am Soc Nephrol. 2011 Aug;6(8):1838–44.
22.
Le MH, Yeo YH, Cheung R, Wong VW, Nguyen MH. Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016. J Intern Med. 2020, Epub ahead of print.
23.
Zhang Y, Moran AE. Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension Among Young Adults in the United States, 1999 to 2014. Hypertension. 2017 Oct;70(4):736–42.
24.
Russell E, Oh KM, Zhao X. Undiagnosed diabetes among Hispanic and white adults with elevated haemoglobin A1c levels. Diabetes Metab Res Rev. 2019 Jul;35(5):e3153.
25.
Executive Order on Advancing American Kidney Health. [Accessed September 1, 2019]. Available from: https://www.whitehouse.gov/presidential-actions/executive-order-advancing-american-kidney-health/.
26.
Chin HJ, Ahn JM, Na KY, Chae DW, Lee TW, Heo NJ, et al. The effect of the World Kidney Day campaign on the awareness of chronic kidney disease and the status of risk factors for cardiovascular disease and renal progression. Nephrol Dial Transplant. 2010 Feb;25(2):413–9.
27.
Devraj R, Borrego ME, Vilay AM, Pailden J, Horowitz B. Awareness, self-management behaviors, health literacy and kidney function relationships in specialty practice. World J Nephrol. 2018 Jan;7(1):41–50.
28.
Saunders MR, Snyder A, Chin MH, Meltzer DO, Arora VM, Press VG. Health Literacy Not Associated with Chronic Kidney Disease Awareness. Health Lit Res Pract. 2017 Sep;1(3):e117–27.
29.
Ravera M, Noberasco G, Weiss U, Re M, Gallina AM, Filippi A, et al. CKD awareness and blood pressure control in the primary care hypertensive population. Am J Kidney Dis. 2011 Jan;57(1):71–7.
30.
KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3:1–150.
31.
KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int Suppl. 2012;2:337–414.
32.
Wanner C, Tonelli M; Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney Int. 2014 Jun;85(6):1303–9.
33.
Tuot DS, Zhu Y, Velasquez A, Espinoza J, Mendez CD, Banerjee T, et al. Variation in Patients’ Awareness of CKD according to How They Are Asked. Clin J Am Soc Nephrol. 2016 Sep;11(9):1566–73.
34.
Leek RB, Park JM, Koerschner C, Mawby J, Sonnenday CJ, Wright Nunes JA, et al. Novel educational and goal-setting tool to improve knowledge of chronic kidney disease among liver transplant recipients: A pilot study. PLoS One. 2019 Jul;14(7):e0219856.
© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.